Long-Acting HIV ART: Lessons From a Year of Cabenuva
Cabenuva, the first long-acting injectable drug for HIV treatment, was approved in January and is slowly rolling out to clinics and patients nationwide.
Medscape Medical News
source https://www.medscape.com/viewarticle/961921?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/961921?src=rss
Comments
Post a Comment